The five-blades scratcher for rhinophyma: a clinical trial

注册号:

Registration number:

ITMCTR2000003779

最近更新日期:

Date of Last Refreshed on:

2020-08-27

注册时间:

Date of Registration:

2020-08-27

注册号状态:

Registration Status:

预注册

Prospective registration

注册题目:

五刃刀划痕术治疗鼻赘型酒渣鼻的临床研究

Public title:

The five-blades scratcher for rhinophyma: a clinical trial

注册题目简写:

English Acronym:

研究课题的正式科学名称:

五刃刀划痕术治疗鼻赘型酒渣鼻的临床研究

Scientific title:

The five-blades scratcher for rhinophyma: a clinical trial

研究课题的正式科学名称简写:

Scientific title acronym:

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

ChiCTR2000037289 ; ChiMCTR2000003779

申请注册联系人:

李文

研究负责人:

李文

Applicant:

Li Wen

Study leader:

Li Wen

申请注册联系人电话:

Applicant telephone:

+86 13917367207

研究负责人电话:

Study leader's telephone:

+86 13917367207

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

13917367207@163.com

研究负责人电子邮件:

Study leader's E-mail:

13917367207@163.com

申请单位网址(自愿提供):

Study leader's website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website
(voluntary supply):

申请注册联系人通讯地址:

上海市浦东新区张衡路528号

研究负责人通讯地址:

上海市浦东新区张衡路528号

Applicant address:

528 Zhangheng Road, Pudong New Area, Shanghai, China

Study leader's address:

528 Zhangheng Road, Pudong New Area, Shanghai, China

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

上海中医药大学附属曙光医院

Applicant's institution:

Shuguang Hospital Affiliated to Shanghai University of TCM

是否获伦理委员会批准:

Approved by ethic committee:

伦理委员会批件文号:

Approved No. of ethic committee:

2020-sgys-017

伦理委员会批件附件:

Approved file of Ethical Committee:

View

批准本研究的伦理委员会名称:

上海中医药大学附属曙光医院伦理委员会

Name of the ethic committee:

IRB of Shuguang Hospital Affiliated to Shanghai University of TCM

伦理委员会批准日期:

Date of approved by ethic committee:

2013/8/24 0:00:00

伦理委员会联系人:

耿希

Contact Name of the ethic committee:

Geng Xi

伦理委员会联系地址:

上海市浦东新区张衡路528号

Contact Address of the ethic committee:

528 Zhangheng Road, Pudong New Area, Shanghai, China

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

上海中医药大学附属曙光医院

Primary sponsor:

Shuguang Hospital Affiliated to Shanghai University of TCM

研究实施负责(组长)单位地址:

上海市浦东新区张衡路528号

Primary sponsor's address:

528 Zhangheng Road, Pudong New Area, Shanghai, China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

上海

市(区县):

Country:

China

Province:

Shanghai

City:

单位(医院):

曙光医院

具体地址:

浦东新区张衡路528号

Institution
hospital:

Shuguang Hospital Affiliated to Shanghai University of TCM

Address:

528 Zhangheng Road, Pudong New Area

经费或物资来源:

上海申康发展中心促进市级医院临床技能与临床创新三年行动计划(2020-2022年)重大临床研究项目

Source(s) of funding:

Shanghai Shenkang Development Center to promote clinical skills and clinical innovation in municipal hospitals three-year action plan (2020-2022) major clinical research projects

研究疾病:

鼻赘型酒渣鼻

研究疾病代码:

Target disease:

Rhinophyllous rosacea

Target disease code:

研究类型:

Study type:

干预性研究

Interventional study

研究设计:

Study design:

随机平行对照

randomized controlled trial(parallel group design)

研究所处阶段:

Study phase:

其它

Others

研究目的:

(1)采用随机对照方法研究五刃刀划痕术治疗中重度鼻赘期酒渣鼻的临床疗效,客观评价该法的高效性和安全性。 (2)规范合理应用五刃刀划痕术治疗中重度鼻赘期酒渣鼻。

Objectives of Study:

(1) A randomized controlled study was conducted to study the clinical efficacy of five-blade knife scratch in the treatment of moderate to severe rosacea, and to objectively evaluate the efficiency and safety of this method. (2) Standard and reasonable application of five-blade knife scratch in the treatment of moderate to severe rhinoplasty stage rosacea.

药物成份或治疗方案详述:

Description for medicine or protocol of treatment in detail:

纳入标准:

符合《中国玫瑰痤疮诊疗专家共识(2016)》中酒渣鼻临床表现及分期为鼻赘期。病程长久者,鼻部结缔组织增生,皮脂腺异常增大,使鼻尖部肥大,形成大小不等的结节状隆起,称为鼻赘,表面不平,皮脂腺口明显增大,压挤有白色皮脂溢出,毛细血管明显扩张。同时满足按照E1-Azhary分类标准诊断为中度(上皮增生形成较小的结节)和重度(巨大的结节)的酒渣鼻患者。 纳入标准 ① 符合上述诊断标准; ② 年龄18~75岁,性别不限; ③ 签署知情同意书并参与试验及随访。

Inclusion criteria

It conforms to the consensus of Experts on The Diagnosis and Treatment of Rosacea in China (2016), and the clinical manifestations and stages of rosacea are rhinophytosis. Long course of disease, the nose connective tissue hyperplasia, abnormal increase of sebaceous glands, so that the tip of the nose hypertrophy, the formation of different size nodular eminence, known as nasal excrescents, uneven surface, sebaceous gland mouth significantly increased, there is white sebaceous overflow, capillary obvious expansion. At the same time, patients with rosacea who met the e1-Azhary classification criteria were diagnosed as moderate (epithelial hyperplasia with small nodules) and severe (giant nodules). Inclusion criteria 1. Meet the above diagnostic criteria; 2. Aged 18-75 years, regardless of gender; 3. Sign informed consent and participate in the trial and follow-up.

排除标准:

① 妊娠、准备妊娠及哺乳期妇女; ② 合并有其他可能引起面部红外、丘疹脓疱的疾病,如脂溢性皮炎、寻常痤疮、激素依赖性皮炎等; ③ 合并有严重心、肝、肺、肾等内科疾病的患者; ④ 瘢痕体质者。

Exclusion criteria:

1. Women who are pregnant, preparing for pregnancy and breast-feeding; 2. With other diseases that may cause facial infrared, papular pustules, such as seborrheic dermatitis, acne vulgaris, hormone-dependent dermatitis, etc.; 3. Patients with serious heart, liver, lung, kidney and other internal diseases; 4. Scar constitution.

研究实施时间:

Study execute time:

From 2020-08-27

To      2022-12-31

征募观察对象时间:

Recruiting time:

From 2020-08-27

To      2022-12-31

干预措施:

Interventions:

组别:

对照组

样本量:

51

Group:

control group

Sample size:

干预措施:

超脉冲二氧化碳激光切割术

干预措施代码:

Intervention:

ultra pulse CO2 laser cutting

Intervention code:

组别:

试验组

样本量:

51

Group:

experimental group

Sample size:

干预措施:

五刃刀划痕术

干预措施代码:

Intervention:

five-blades scratcher

Intervention code:

样本总量 Total sample size : 102

研究实施地点:

Countries of recruitment
and research settings:

国家:

中国

省(直辖市):

上海

市(区县):

Country:

China

Province:

Shanghai

City:

单位(医院):

上海中医药大学附属曙光医院

单位级别:

三级甲等

Institution/hospital:

Shuguang Hospital Affiliated to Shanghai University of TCM

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

鼻形改变

指标类型:

主要指标

Outcome:

Nose change

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

鼻组织

组织:

Sample Name:

Nasal tissue

Tissue:

人体标本去向

使用后销毁

说明

Fate of sample 

Destruction after use

Note:

征募研究对象情况:

正在进行

Recruiting

年龄范围:

最小
Min age years
最大
Max age years

Recruiting status:

Participant age:

性别:

Gender:

男女均可

Both

随机方法(请说明由何人用什么方法产生随机序列):

在临床试验开始前即由与本试验无关的统计人员将治疗组和对照组按照随机数法进行编号。

Randomization Procedure (please state who generates the random number sequence and by what method):

The treatment group and control group were numbered according to random number method by statisticians unrelated to the trial before the clinical trial began.

盲法:

开放

Blinding:

open-label

是否共享原始数据:

IPD sharing:

Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

数据上传 上传到哪里?

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

End to upload

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

病例记录表

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

病例记录表

数据管理委员会:

Data Managemen Committee:

Yes

研究计划书或研究结果报告发表信息
(杂志名称、期、卷、页,时间;或网址):

Publication information of the protocol/research results report
(name of the journal, volume, issue, pages, time; or website):

ITMCTR BJ-ICP:07032215-5 Tip: IE8 is recommended Use the system with widescreen display resolution above